Description

Lipid profile analysis of brain tissue showing incorporation of dietary MCFAs and omega-3 PUFAs into neural membrane phospholipids.

Figure 7

Chart

Source Paper

The Impact of Medium Chain and Polyunsaturated ω-3-Fatty Acids on Amyloid-β Deposition, Oxidative Stress and Metabolic Dysfunction Associated with Alzheimer's …

Antioxidants (Basel, Switzerland) (2021)

PMID: 34943094

DOI: 10.3390/antiox10121991

Cite This Figure

![Figure 7: Lipid profile analysis of brain tissue showing incorporation of dietary MCFAs and omega-3 PUFAs into neural membrane phospholipids.]()

> Source: Janine Mett "The Impact of Medium Chain and Polyunsaturated ω-3-Fatty Acids on Amyloid-β Depo." *Antioxidants (Basel, Switzerland)*, 2021. PMID: [34943094](https://pubmed.ncbi.nlm.nih.gov/34943094/)

<figure>
  <img src="" alt="Lipid profile analysis of brain tissue showing incorporation of dietary MCFAs and omega-3 PUFAs into neural membrane phospholipids." />
  <figcaption>Figure 7. Lipid profile analysis of brain tissue showing incorporation of dietary MCFAs and omega-3 PUFAs into neural membrane phospholipids.<br>  Source: Janine Mett "The Impact of Medium Chain and Polyunsaturated ω-3-Fatty Acids on Amyloid-β Depo." <em>Antioxidants (Basel, Switzerland)</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34943094/">34943094</a></figcaption>
</figure>

Preuves associées

Omega-3 Fatty Acids (DHA/EPA) pour Mild Cognitive Impairment (MCI)

Note B · 18 études